title: Weight-Loss Effect on FVC in Nintedanib Idiopathic Pulmonary Fibrosis Trials?
authors.affiliation: 1 University of Toledo Toledo, Ohio.
authors.forename: Ragheb
authors.initials: R
authors.lastname: Assaly
authors.affiliation: 1 University of Toledo Toledo, Ohio.
authors.forename: Abdur Rahman
authors.initials: AR
authors.lastname: Khan
authors.affiliation: 1 University of Toledo Toledo, Ohio.
authors.forename: Dan E
authors.initials: DE
authors.lastname: Olson
mesh_terms: D004791:Enzyme Inhibitors / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000188:drug therapy*; D007211:Indoles / Q000008:administration & dosage*; D008297:Male; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage*
chemical_list: D004791:Enzyme Inhibitors; D007211:Indoles; D047428:Protein Kinase Inhibitors